2-(4-(2-hydroxy-3-(isopropylamino)propoxy)phenyl)acetic acid hydrochloride; 4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetic Acid; 4-(2-Hydroxy-3-isopropylaminopropoxy)phenylacetic Acid; Atenolol Acid; H 117/04; SL 77-010; Atenolol Impurity G (EP); Atenolol Impurity G; Atenolol USP Related Compound C; Metoprolol Acid
Atenolol EP Impurity G Sodium Salt is a fully characterized chemical compound used as a reference standard of API Lumacaftor. The standard offered is compliant with regulatory guidelines. Atenolol EP Impurity G Sodium Salt is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - NA
